India - Pesticides - Syngenta I

Syngenta pesticides endanger farmers and plantation workers

India - Pesticides - Syngenta I

Syngenta pesticides endanger farmers and plantation workers

Swiss chemical company Syngenta, one of the world’s biggest agribusiness companies, markets highly harmful pesticides in India. After Bayer, Syngenta is the second biggest pesticides firm in the Indian market. Gramoxone, one of the products Syngenta sells in India, contains the active ingredient Paraquat which is highly toxic and can lead to death if inhaled.

Paraquat was banned in the European Union in 2007, and in the USA Gramoxone must include the warning “fatal in inhaled.” But this warning is not included on the product sold in India, which states only “fatal if swallowed.” This was uncovered in research for the ECCHR monitoring report submitted in October 2015 to the Panel of Experts on Pesticides Management at the UN Food and Agriculture Organization (FAO).


The research by ECCHR and PAN AP shows that Syngenta’s Gramoxone (active ingredient: Paraquat) – which is banned in many countries including throughout the EU – is used on plantations in Indonesia and the Philippines with almost no protective measures. Labels on both products are in Hindi and English only, with the result that most people in Punjab cannot understand them.

Despite the high toxicity of Gramoxone, there is no indication of the protective equipment needed for its use. Neither of these Syngenta pesticides includes warnings against using the containers for other purposes or information on correct disposal methods. Neither Syngenta nor the plantation owners provide protective equipment suitable for the climate in these countries. There is very limited access to adequate medical care. Scientific studies have identified several serious health problems and long term harm linked to the use of Paraquat.


In April 2016, ECCHR, the Pesticide Action Network Asia Pacific, and Public Eye presented Syngenta with the results of a survey of plantation workers on the effects of Gramoxone on the health of workers on two plantations in Indonesia and another in the Philippines. The submission documents interviews conducted with 39 workers in both countries and compares the results with Syngenta’s recommendations on the use of its products.

Syngenta must be aware of the conditions in Indonesia and the Philippines. But according to a response sent to ECCHR, the Swiss company has no plans to change how Paraquat/Gramoxone is sold. Syngenta merely referred to general training measures and promised to carry out its own follow-up research but has to date refused to make the results of this research available to ECCHR. Syngenta also maintains what it calls its “safe use” position, under which a pesticide causes no harm when used correctly. This approach disregards the actual conditions on the plantations in question.

Related Topics

Related Cases


States produce national action plans on business and human rights to implement the UN Guiding Principles on Business and Human Rights.
Monitoring reports can be submitted to certain organizations to highlight important issues.
The UN Guiding Principles on Business and Human Rights aim to promote corporate responsibility for human rights.
A company's s human rights due diligence obligations reguire it to manage potential risks to human rights.